share_log
  • Headlines
  • crmi (08158) announced its interim results, with a net profit of 16.828 million Hong Kong dollars, a year-on-year increase of 31.86%.

中国再生医学(08158)公布中期业绩 净利1682.8万港元 同比增长31.86%

crmi (08158) announced its interim results, with a net profit of 16.828 million Hong Kong dollars, a year-on-year increase of 31.86%.

Zhitong Finance ·  Aug 23 22:43

CRMI (08158) announced its mid-term performance for 2024, with a profit of HKD 59.785 million, a decrease of...

According to the Smart Finance app, CRMI (08158) announced its mid-term performance for 2024, with a profit of HKD 59.785 million, a decrease of 19.44% year-on-year; a net profit of HKD 16.828 million, an increase of 31.86% year-on-year; earnings per share of HKD 5.53 cents.

According to the announcement, the overall decrease in revenue is mainly due to retaliatory consumption by mainland Chinese customers after the lifting of epidemic prevention measures in 2023, which is not the case in 2024.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated